Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

James Pelham

Pediatrics Birmingham, AL Medical Doctor

NPI 1760916241 CMS profile 7714177

2815 Independence Dr, Birmingham, AL 35209

Open in the dashboard

General payments

$4,383

194 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Pelham of Birmingham, AL is reported in the CMS Open Payments database as having received $4,383 across 194 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,033 50
2024 General $1,459 49
2023 General $804 34
2022 General $720 44
2021 General $368 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Pelham
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to James Pelham were reported at $1,033. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year James Pelham Pediatrics median Middle half National median
2019 $0 $86 $31–$183 $163
2020 $0 $49 $22–$110 $114
2021 $368 $68 $27–$158 $132
2022 $720 $77 $30–$173 $149
2023 $804 $88 $33–$190 $160
2024 $1,459 $94 $34–$206 $164
2025 $1,033 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Supernus Pharmaceuticals, Inc. $1,018 38 payments
  2. Corium, Inc. $928 41 payments
  3. Ironshore Pharmaceuticals Inc. $551 29 payments
  4. ALK-Abello, Inc $321 19 payments
  5. Tris Pharma Inc $316 14 payments
  6. Sanofi-Aventis U.S. LLC $270 8 payments
  7. Sanofi Pasteur Inc. $171 4 payments
  8. Verrica Pharmaceuticals Inc. $125 1 payment
  9. Neos Therapeutics, LP $106 6 payments
  10. ACADIA Pharmaceuticals Inc $91 5 payments
  11. Other $486 29 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,383 194 payments
Products named General payments · program years 2021–2025
  1. Azstarys $928 41 payments
  2. Qelbree Viloxazine Hydrochloride $751 25 payments
  3. Grastek $321 19 payments
  4. Odactra $321 19 payments
  5. JORNAY PM Central Nervous System Stimulant $307 18 payments
  6. TZIELD $270 8 payments
  7. QELBREE Psychology $267 13 payments
  8. JORNAY PM Central Nervous Stimulant ADHD $244 11 payments
  9. Ragwitek $227 14 payments
  10. Dyanavel XR $183 4 payments
  11. Other $1,754 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

194 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record